Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025)

Sensus Healthcare has reported Cash from Financing Activities over the past 9 years, most recently at -$5000.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$5000.0 for Q4 2025, down 117.86% from a year ago — trailing twelve months through Dec 2025 was -$305000.0 (down 535.42% YoY), and the annual figure for FY2025 was -$305000.0, down 2133.33%.
  • Cash from Financing Activities for Q4 2025 was -$5000.0 at Sensus Healthcare, up from -$300000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for SRTS hit a ceiling of $273000.0 in Q1 2022 and a floor of -$1.9 million in Q4 2022.
  • Median Cash from Financing Activities over the past 5 years was -$39000.0 (2023), compared with a mean of -$200400.0.
  • Peak annual rise in Cash from Financing Activities hit 555.0% in 2022, while the deepest fall reached 3481.48% in 2022.
  • Sensus Healthcare's Cash from Financing Activities stood at -$54000.0 in 2021, then plummeted by 3481.48% to -$1.9 million in 2022, then soared by 99.64% to -$7000.0 in 2023, then surged by 500.0% to $28000.0 in 2024, then crashed by 117.86% to -$5000.0 in 2025.
  • The last three reported values for Cash from Financing Activities were -$5000.0 (Q4 2025), -$300000.0 (Q1 2025), and $28000.0 (Q4 2024) per Business Quant data.